Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women

Cyclin dependent kinase inhibitor 2B (CDKN2B) encodes a cyclin-dependent kinase inhibitor that may enhance the formation of atherosclerotic plaques. The aim of the present study was to investigate the contribution of CDKN2B promoter methylation on the risk of coronary heart disease (CHD). The presen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Chen, Xiaomin, Jiang, Danjie, Xu, Limin, Han, Liyuan, Hu, Haochang, Huang, Yi, Lu, Deyi, Ji, Huihui, Li, Bin, Yang, Yong, Zhou, Cong, Xu, Xuting, Wu, Nan, Xu, Xiaofeng, Xu, Yan, Shen, Yusheng, Li, Jiyi, Duan, Shiwei
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307461/
https://ncbi.nlm.nih.gov/pubmed/30651784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados